FDBusiness.com

New Clinical Trial Backs Arla Foods Ingredients’ Infant Immunity Ingredient

 Breaking News
  • New Chief Executive For Tate & Lyle Tate & Lyle, a global provider of ingredients and solutions to the food, beverage and other industries, with operations in over 30 locations worldwide, has appointed Nick Hampton as Chief Executive with effect from 1 April 2018. Nick Hampton is currently Chief Financial Officer and a Board member of Tate & Lyle. Nick Hampton succeeds Javed [...]...
  • Müller Direct Next Generation Müller, Britain’s biggest producer of branded and private label fresh milk, butter, yogurt, desserts and dairy ingredients, has announced a new initiative to help ambitious young farmers build vibrant dairy businesses for the future. Müller will initially work closely with a group of approximately 25 Müller Direct young farmers who have the potential to create [...]...
  • New Geographical Indication From the Netherlands The Commission has approved the addition of a new product from The Netherlands to the quality register of Traditional Speciality Guaranteed (TSG). ‘Suikerstroop’ is dark brown syrup made of the syrupy liquid left behind during the production of sugar from sugar beet or sugar cane. It has a sweet taste due to its large sugar content (at [...]...
  • Firmenich Extends Capability to Design Innovative and Sustainable Natural Ingredients Firmenich has established an exclusive partnership with Blue Marble Biomaterials, a leading US biotechnology company specialized in natural and sustainable ingredients. With this partnership Firmenich gains direct access to key expertise, from biomimicry to non-GM fermentation, enabling the design of innovative and sustainable natural ingredients for the food, beverage and flavor industries. “At Firmenich, we are committed to [...]...
  • Tetra Pak Pledges Support For EU Plastics Strategy Tetra Pak has pledged to support the European Commission’s Plastics Strategy, announced as part of the EU Action Plan for a Circular Economy. The company will: Work with industry partners to ensure that by 2030, recycling solutions are in place for all components of beverage cartons so they can be fully recycled across Europe; Substantially increase the use [...]...

New Clinical Trial Backs Arla Foods Ingredients’ Infant Immunity Ingredient

February 06
10:33 2014

Feeding babies with infant formula enriched with Arla Foods Ingredients’ Lacprodan® OPN-10 supports their immune development, according to the results of a new trial.

Lacprodan® OPN-10 is made from the whey protein osteopontin, a bioactive component associated with the maturation of the infant immune system. Osteopontin is found in high concentrations in human milk – about 138mg per litre – but in much lower concentrations in bovine milk (about 15mg per litre). This means infants fed regular formula have a limited intake compared with their breastfed counterparts.

Researchers from China’s Fundan University Hospital and the University of California at Davis conducted a double-blind randomised clinical trial in which Chinese infants aged between one and six months were fed either regular infant formula or infant formula supplemented with Lacprodan® OPN-10, with both groups compared with a reference group of breastfed babies.

The results showed that the babies who were given infant formula supplemented with Lacprodan® OPN-10 experienced a similar number of days of fever to those fed breast milk, and a reduced number of days of fever compared with a control group fed ordinary infant formula. The study also demonstrated that Lacprodan® OPN-10 is safe for use in infant formula.

The findings from the as-yet unpublished study were presented last week by Professor Bo Lönnerdal of the University of California at Davis during the 2nd International Conference on Nutrition & Growth, which took place from 30 January to 1 February 2014 in Barcelona, Spain.

Lotte Neergaard Jacobsen, Nutrition Scientist atArla Foods Ingredients, said: “The development of Lacprodan® OPN-10 is part of the quest to create infant formula that is more like breast milk. The results from this clinical study show that we have moved a step closer to achieving this. Osteopontin in the form of Lacprodan® OPN-10 could be a significant missing link in creating infant formula that can deliver a similar level of immune protection to that offered by mother’s milk.”

Experts at Arla Foods Ingredients have developed and patented the purification of osteopontin from cows’ milk and its application in infant and follow-on formulas, making it possible to create products with the same concentration of osteopontin as breast milk.

About Author

colin

colin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • January 17, 2018Anfas Food Product
  • January 19, 2018International Green Week
  • January 20, 2018Sigep Rimini
  • January 24, 2018International Bulk Wine and Spirits Show (IBWSS)
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements